← Leaderboards
Nathan Singh
Washington University
$1,879,185
Attributed
$1,879,185
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $355.7K · FY2019–25$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,879,185 · 2
By mechanism
K08$1,167,773 · 1
R37$711,412 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- John F Dipersio$33,235,840
- Shrikant Anant$8,735,951
- Timothy J Ley$36,060,228
- Takeshi Egawa$8,683,159
- Vineet Gupta$8,266,585
Others in their field
Other Emerging Leaders on “Leukemia”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,967,203
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$22,728,591
- Crystal Mackall · Children'S Hosp Of Philadelphia$13,752,686
- Leonard Freedman · Leidos Biomedical Research, Inc.$12,170,219
- Geoffrey Roger Hill · Fred Hutchinson Cancer Center$10,343,043
Research focus
LeukemiaProgramsEngineered T CellsIn VivoMediatingPathway InteractionsChimeric Antigen ReceptorCytotoxicityGenesIn VitroLeukemia/LymphomaMalignant NeoplasmsMolecularMouse ModelCell PhysiologyCellsCancer ImmunotherapyChimeric Antigen Receptor T CellsCell TherapyFailureCd19 GeneInsightCellular ImmunotherapyReceptor
Grant awards (7)
Decoding 41BB-specific dysfunction programs in cellular immunotherapies for cancer$355,706
R37 · FY2025 · CA · contact PI
Decoding 41BB-specific dysfunction programs in cellular immunotherapies for cancer$355,706
R37 · FY2024 · CA · contact PI
Mechanisms regulating chimeric antigen receptor T-cell activity in cancer$238,135
K08 · FY2023 · CA · contact PI
Mechanisms regulating chimeric antigen receptor T-cell activity in cancer$238,135
K08 · FY2022 · CA · contact PI
Mechanisms regulating chimeric antigen receptor T-cell activity in cancer$238,135
K08 · FY2021 · CA · contact PI
Mechanisms regulating chimeric antigen receptor T-cell activity in cancer$226,684
K08 · FY2020 · CA · contact PI
Mechanisms regulating chimeric antigen receptor T-cell activity in cancer$226,684
K08 · FY2019 · CA · contact PI